Data thru May 13, 2026
HomeTrendsArticlesDrug MarketsTherapeutic ClassesManufacturersPricingContact
Back to Market Feed

ZEMBRACE SYMTOUCH 3 MG/0.5 ML

Sumatriptan Succinate
$383.9790per ML
High Outlier

Strength

3 mg/1

Manufacturer

Upsher-Smith Laboratories LLC

NDC

00245080938

Classification

Brand

Dosage Form

INJECTION, SOLUTION

Route

SUBCUTANEOUS

Last Updated

4/22/2026

Active Ingredients

SUMATRIPTAN SUCCINATE

Approval Type

New Drug (NDA)

FDA Application

NDA208223

On Market Since

2/22/2016

Pharmacological Classes

Serotonin 1b Receptor Agonists
Serotonin 1d Receptor Agonists
Serotonin-1b and Serotonin-1d Receptor Agonist

Price History

1W

0.0%

1M

-0.2%

3M

+0.5%

6M

+0.2%

1Y

+0.1%

3Y

+15.9%

5Y

+16.3%

All

+16.3%

Generic Alternatives

1 alternative • Same active ingredient

ZEMBRACE SYMTOUCH 3 MG/0.5 ML
Brand
70792080938•Tonix Medicines, Inc.
$383.9786

Related Drugs

Same classification

MAXALT MLT 10 MG TABLET
Brand
78206014301•Organon LLC
$44.3130
per EA
MAXALT 10 MG TABLET
Brand
78206014201•Organon LLC
$44.4765
per EA
IMITREX 100 MG TABLET
Brand
00173073701•GlaxoSmithKline LLC
$72.5313
per EA
IMITREX 50 MG TABLET
Brand
00173073601•GlaxoSmithKline LLC
$73.0682
per EA
RELPAX 40 MG TABLET
Brand
00049234005•Roerig
$77.1492
per EA
RELPAX 40 MG TABLET
Brand
58151036856•Viatris Specialty LLC
$77.1492
per EA
RELPAX 40 MG TABLET
Brand
58151036896•Viatris Specialty LLC
$77.1492
per EA
RELPAX 20 MG TABLET
Brand
00049233045•Roerig
$77.3165
per EA
RELPAX 20 MG TABLET
Brand
58151036756•Viatris Specialty LLC
$77.3165
per EA
TOSYMRA 10 MG NASAL SPRAY
Brand
00245081261•Upsher-Smith Laboratories LLC
$108.1537
per EA

Data Source

Pricing data sourced from the National Average Drug Acquisition Cost (NADAC) survey, published by the Centers for Medicare & Medicaid Services (CMS). Updated weekly.

Disclaimer

This site is for informational purposes only and does not constitute medical, pharmaceutical, or financial advice. NADAC prices are survey-based estimates and may not reflect actual acquisition costs at any specific pharmacy.

Navigate

HomeAboutManufacturersDrug MarketsTherapeutic ClassesTrendsArticlesPricingContact

© 2026 NADAC Intelligence. All rights reserved. Not affiliated with CMS or any government agency.

Terms of ServicePrivacy Policy